Kirk Dornbush

investor type
Angel Investors
stage focus
Seed Round
Mr. Dornbush has served as Chief Financial Officer and Director of Iconic Therapeutics, Inc. since its inception in 2002. In April 2007, he was additionally appointed as President of the Company. As President, Mr. Dornbush is responsible for all d...
Show more
Relevant investments:
Company
Cost
Round
  • Super company
    Billion
  • Foundersuite
    Million
    Seed A
  • Active Inv
    13 000
    Round Best
Show more